by Stacey Hawkins | Feb 9, 2017 | Genetic Disease
FIRST THERAPY APPROVED FOR SMA Squeaking by on December 23rd as the last new drug approval of 2016, Biogen’s (Cambridge, MA) Spinraza now provides hope for the thousands of families affected by a debilitating neuromuscular disorder known as spinal muscular atrophy... 
by Stacey Hawkins | Jan 7, 2016 | Regulation
Treatment Options Broaden Driven by 19 new orphan approvals, a whopping 45 novel drugs were cleared for the marketplace in 2015. Additionally, new approvals opened up treatment options for Americans with diseases ranging from breast and lung cancers to irritable bowel... by Stacey Hawkins | Mar 13, 2014 | Regulation
ALPHABET SOUP: NEW DRUG APPROVALS Acronyms abound in the world of new drug approvals. Check out our cheat sheet below for help with some of the most common: BLA: Biologic Licensing Application Planning on developing a biologic drug? Would you like to bring it to...
